Miyoshi Muscular Dystrophy 3 (MMD3)

Miyoshi Muscular Dystrophy 3(来自ICD-11)
别称:
Mmd3
Miyoshi Myopathy 3
Dystrophy, Muscular, Miyoshi, Type 3
Miyoshi Muscular Dystrophy Type 3
Distal Anoctaminopathy
加入收藏
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Miyoshi Muscular Dystrophy 3, also known as mmd3, is related to gnathodiaphyseal dysplasia and limb-girdle muscular dystrophy, and has symptoms including calf muscle weakness An important gene associated with Miyoshi Muscular Dystrophy 3 is ANO5 (Anoctamin 5), and among its related pathways/superpathways are Transport of inorganic cations/anions and amino acids/oligopeptides and SARS-CoV-2 Infection. Affiliated tissues include skeletal muscle, and related phenotypes are distal lower limb muscle weakness and progressive muscle weakness
查看原文 参与反馈
相关ID:

基础信息

遗传方式
发病时间
患病率/发病率
相关基因
相关模型
参考文献
MALACARDS
AR
Adolescent
<1/1000000
16
129
5

疾病表征

#
分类
表征
HPO概率
Orphanet概率
HPO来源
暂无相关数据

基因 & 突变

#
基因
作用分类
分值
突变数量
暂无相关数据

靶点药物

药物名称
CAS号
研发状态
临床阶段
暂无相关数据

疾病模型

类型
名称
MGI
相关基因
品系来源
文献数量
暂无相关数据

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top